Tag: biotech investment
-
BioLineRx Wins USPTO Notice of Allowance for GLIX1 Cancer Therapy Patent Across Most Cancers
Overview: A Major Step Forward for GLIX1 BioLineRx announced a significant milestone in its cancer therapy program with a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its key patent covering GLIX1. This development marks an important expansion of protection for GLIX1 as a potential treatment for a broad range…
-
China’s Spectacular Leap in Therapeutic Innovation: Breakthroughs in Cancer, Immunology, and Diabetes
China’s Breakthroughs in Therapeutic Innovation: Cancer, Immunology, and Diabetes In the past decade, China has transitioned from a manufacturing powerhouse to a global leader in therapeutic innovation. A convergence of ambitious public policy, expansive funding, and a fast-evolving regulatory framework has accelerated the development and approval of new therapies. The result is a chorus of…